ELISA Kit for Interleukin 3 Receptor Alpha (IL3Ra)

Assay length:

3h

Detection range:

0.312-20ng/mL

Organism species:

Homo sapiens (Human)

Method:

Double-antibody Sandwich

Item Name:

Interleukin 3 Receptor Alpha

Format:

48T, 96T, 96T×5, 96T×10, 96T×100

Research Area:

Signal transduction;CD & Adhesion molecule;

Application:

Enzyme-linked immunosorbent assay for Antigen Detection.

Alternative Names:

CD123; IL3R-A; IL3RY; IL3RAY; IL3R; IL3RAY; IL3RY; hIL-3Ra

Test:

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Sample type:

serum, plasma, tissue homogenates and other biological fluids

Sensitivity:

The minimum detectable dose of this kit is typically less than 0.129ng/mL

Properties:

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays

Stability:

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Description:

The ELISA Kit for Interleukin 3 Receptor Alpha (IL3Ra) is a α- or alpha protein sometimes glycoprotein present in blood.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.